This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
这位Abbott分析师开始看好的报告; 以下是周二的前五个新規投资
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
华尔街顶级分析师改变了对这些顶级公司的展望。如需查看包括升级和降级在内的所有分析师评级变化的完整视图，请参阅我们的分析师评级页面。
- Oppenheimer analyst Suraj Kalia initiated coverage on Abbott Laboratories (NYSE:ABT) with an Outperform rating and announced a price target of $130. Abbott shares gained 0.6% to close at $113.36 on Monday. See how other analysts view this stock.
- Wells Fargo analyst Eva Fortea Verdejo initiated coverage on Arcus Biosciences, Inc. (NYSE:RCUS) with an Overweight rating and announced a price target of $29. Arcus Biosciences shares gained 3.9% to close at $17.30 on Monday. See how other analysts view this stock.
- Susquehanna analyst Charles Minervino initiated coverage on Howmet Aerospace Inc. (NYSE:HWM) with a Positive rating and announced a price target of $120. Howmet Aerospace shares gained 0.8% to close at $102.83 on Monday. See how other analysts view this stock.
- Morgan Stanley analyst Judah Frommer initiated coverage on Bicara Therapeutics Inc. (NASDAQ:BCAX) with an Overweight rating and announced a price target of $35. Bicara Therapeutics shares fell 2.8% to close at $24.45 on Monday. See how other analysts view this stock.
- Hovde Group initiated coverage on First National Corporation (NASDAQ:FXNC) with an Outperform rating and announced a price target of $22. First National shares gained 0.9% to close at $18.37 on Monday. See how other analysts view this stock.
- Oppenheimer分析师Suraj Kalia开始覆盖雅培（纽交所：ABT），给予跑赢市场评级，并宣布目标价为130美元。周一雅培股票上涨0.6％，收于113.36美元。看看其他分析师如何看待这支股票。
- Wells Fargo分析师Eva Fortea Verdejo开始覆盖arcus biosciences，公司（纽交所：RCUS），给予增持评级，并宣布目标价为29美元。周一Arcus Biosciences股票上涨3.9％，收于17.30美元。看看其他分析师如何看待这支股票。
- Susquehanna分析师Charles Minervino开始覆盖howmet aerospace公司（纽交所：HWM），给予积极评级，并宣布目标价为120美元。周一howmet aerospace股票上涨0.8％，收于102.83美元。看看其他分析师如何看待这支股票。
- 摩根士丹利分析师Judah Frommer开始覆盖Bicara Therapeutics公司（纳斯达克：BCAX），给予增持评级，并宣布目标价为35美元。周一Bicara Therapeutics股票下跌2.8％，收于24.45美元。看看其他分析师如何看待这支股票。
- Hovde Group开始覆盖first national公司（纳斯达克：FXNC），给予跑赢市场评级并宣布目标价为22美元。周一first national股票上涨0.9％，收于18.37美元。看看其他分析师如何看待这支股票。
Considering buying ABT stock? Here's what analysts think:
考虑购买ABT股票吗？以下是分析师的看法：
Read More:
阅读更多：
- Dow Dips Around 400 Points As Treasury Yields Top 4%: Investor Optimism Declines, But Fear Index Remains In 'Greed' Zone
- 道指下跌约400点，美国国债收益率超过4%：投资者乐观情绪下降，但恐惧指数仍处于'贪婪'区域